Journal of Cell Science & Therapy
Open Access

Advancing Bone Tissue Engineering: Harnessing Mesenchymal Stem Cell-Immune Cell Interactions for Enhanced Regeneration

Yi Wang^{* *}Correspondence: Yi Wang, Department of Orthopedics, Nanjing Medical University, Suzhou, China, Email:

Author info »

Description

There are still issues to be resolved internationally about serious bone abnormalities and the associated delayed union and nonunion. Bone reconstruction is the major objective of bone tissue engineering. Being a kind of pluripotent stem cell that can develop into bone cells, mesenchymal stem cells (MSCs) are one of the fundamental building blocks of bone tissue engineering.

Although though bone tissue has the ability to mend itself during bone regeneration, major bone flaws brought on by severe fractures, tumour removal, congenital deformities, arthritis, and osteoporosis continue to be a global problem since regenerative needs outweigh the bone's ability to heal itself [1].

The gold standard for surgical bone repair is autologous bone grafting, however its usage is restricted due to possible risks such persistent discomfort, infections, and hematomas.

Other treatments for serious bone abnormalities include allogenic and xenogenic bone grafting, but these procedures have significant drawbacks, such as high costs, risks of disease transmission, and immunological rejection [2].

However, due to the drawbacks of conventional bone transplants, innovative bone regeneration techniques for serious bone abnormalities should be created.

Critical bone abnormalities may be treated by bone tissue engineering, which has four components: biomaterial scaffolds, stem cells, bioactive substances, and biophysical stimulation [3].

The majority of recent studies, however, have mainly concentrated on osteogenesis and angiogenesis during bone healing because osteogenesis stimulates the deposition of collagen and hydroxyapatite and angiogenesis promotes the delivery of oxygen and nutrients for bone cells to carry out their functions. Nevertheless, immune cells and released cytokines are crucial for the immune system's critical impacts on bone healing [4].

Acute inflammation brought on by damaging factors like trauma often marks the initial stage of inflammation during bone healing. This is followed by a degenerative or regenerative stage defined by the interaction of immune cells with bone cells [5].

Stem cells are one of the fundamental building blocks of bone tissue engineering; mesenchymal stem cells (MSCs) in particular have been extensively exploited for bone repair. MSCs have immunomodulatory activities to interact with different immune cells (such as T cells and macrophages) through cell-cell contact or secreted substances [6]. They may be controlled by different immune cells to move and differentiate.

The osteoinducing actions of immune cells on MSCs for bone repair are discussed in this study. Also described is the immunological regulation of MSCs to immune cells. By focusing on how MSCs and immune cells interact, potential modifications to be exploited in bone tissue creation are evaluated in detail. The major goal of this review is to analyse the relationship between immune cells and MSCs as well as potential regulation techniques [7]. Future investigations on bone tissue engineering that take into account immunomodulation for bone regeneration can be conducted using the review as a foundation.

An essential component of bone repair is inflammation. With the help of phagocytosis, degranulation, and cytokine production, immune cells can produce an immunological milieu that is favourable for bone repair. Moreover, they hasten bone repair. MSCs can develop into bone cells, making them crucial precursor cells for fracture healing. MSCs can be attracted by inflammatory stimulation, which can also control their apoptosis and proliferation, and help them differentiate into osteogenic cells. This study focused on the control and mechanism of immune cells on MSCs.

Multipotent stem cells (MSCs) may differentiate into diverse cell lineages and have anti-inflammatory and immunomodulatory properties. MSCs have the ability to control T lymphocyte and macrophage proliferation and phenotype, stop B lymphocytes from secreting antibodies, stop DC from maturing, and lessen NK cell cytotoxicity. Moreover, MSC-mediated immune modulation is flexible. It is hypothesized that the interaction between MSCs and immune cells has a positive feedback-like impact on the control of bone regeneration when combined with the influence of immune cells on MSCs in osteogenesis. As a result, the immunomodulatory effects of MSCs are discussed.

The use of stem cell treatments can be improved by looking into potential immune regulatory mechanisms.

Conclusion

The interaction between MSCs and immune cells, as well as associated modulations for bone tissue engineering, are the key topics of this study. Immune cells have the ability to encourage MSC recruitment, growth, and osteogenic differentiation in appropriate circumstances. In a variety of cells, MSCs can also have immunomodulatory effects.

Several modulations supply immune cells or MSCs to enhance bone regeneration for serious bone abnormalities by focusing on the interaction between MSCs and immune cells.

Biophysical (internal structural stimuli, external mechanical stimuli, and electromagnetic stimuli) and biochemical (bioactive proteins or peptides, nonamino acid medicines, metal ions, and nanoparticles) stimuli can be employed to control immune cells and encourage MSC osteogenesis. Immune cells for bone repair can be controlled using modified MSCs and systemic MSC injection.

References

1. Yong KW, Choi JR, Choi JY, Cowie AC. Recent advances in mechanically loaded human mesenchymal stem cells for bone tissue engineering. Int J Mol Sci. 2020; 21(16):5816.

   [Crossref]  [PubMed] [Google Scholar]

2. Wang Y, Wang J, Zheng J, Yu M, Cai L, Zhang S,et al. Ectopic osteogenesis by type I collagen loaded with a novel synthesized PTH‐related peptide‐1 in vivo. J Biomed Mater Res. 2020; 108(1):166-177.

   [Crossref]  [PubMed] [Google Scholar]

3. Chen CH, Hsu EL, Stupp SI. Supramolecular self-assembling peptides to deliver bone morphogenetic proteins for skeletal regeneration. Bone. 2020; 141:115-565.

   [Crossref]  [PubMed] [Google Scholar]

4. Yang L, Huang J, Yang S, Cui W, Wang J, Zhang Y, et al. Bone regeneration induced by local delivery of a modified PTH-derived peptide from Nano hydroxyapatite/chitosan coated True bone ceramics. ACS Biomater Sci Eng. 2018;4(9):3246-3258.

   [Crossref]  [PubMed] [Google Scholar]

5. Tang D, Tare RS, Yang LY, Williams DF, Ou KL, Oreffo RO. Biofabrication of bone tissue: approaches, challenges and translation for bone regeneration. Biomaterials. 2016; 83:363-382.

   [Crossref]  [PubMed] [Google Scholar]

6. Liang B, Huang J, Xu J, Li X, Li J. Local delivery of a novel PTHrP via mesoporous bioactive glass scaffolds to improve bone regeneration in a rat posterolateral spinal fusion model. RSC advances. 2018; 8(22):12484-12493.

   [Crossref]  [PubMed] [Google Scholar]

7. Yang N, Liu Y. The role of the immune microenvironment in bone regeneration. Int J Med Sci. 2021;18(16):3697.

   [Crossref]  [PubMed] [Google Scholar]